Clinical Trial Update: Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks [Phase 3]

View source ↗

Summary

Phase 3 trial Cefaliv® vs Neosaldina® for migraine attacks was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Cefaliv®
• Neosaldina®

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Migraine Headache | Phase 3 | Status: WITHDRAWN